Association of vitamin D receptor gene polymorphisms with type 2 diabetes mellitus in Taif population: a case-control study / Associação de polimorfismos do gene do receptor de vitamina D com diabetes mellitus tipo 2 na população Taif: um estudo de caso-controle

Abstract Several reasons may underlie the dramatic increase in type2 diabetes mellitus. One of these reasons is the genetic basis and variations. Vitamin D receptor polymorphisms are associated with different diseases such as rheumatoid arthritis and diabetes. The aim of this study is to investigate the possible association of two identified mutations ApaI (rs7975232) and TaqI (rs731236). Eighty-nine healthy individuals and Fifty-six Type 2 Diabetic (T2D) patients were investigated using RFLP technique for genotyping and haplotyping as well. The distribution of Apal genotypes was not statistically significant among the control (P=0.65) as well as for diabetic patients (P=0.58). For Taql allele frequencies of T allele was 0.61 where of G allele was 0.39. The frequency distribution of Taql genotypes was not statistically significant among the control (P=0.26) as well as diabetic patients (P=0.17). Relative risk of the allele T of Apa1 gene is 1.28 and the odds ratio of the same allele is 1.53, while both estimates were < 1.0 of the allele G. Similarly, with the Taq1 gene the relative risk and the odds ratio values for the allele T are 1.09 and 1.27 respectively and both estimates of the allele C were 0.86 for the relative risk and 0.79 for the odds ratio. The pairwise linkage disequilibrium between the two SNPs Taq1/apa1 was statistically significant in control group (D = 0.218, D' = 0.925 and P value < 0.001) and similar data in diabetic groups (D = 0.2, D' = 0.875 and P value < 0.001). These data suggest that the T allele of both genes Apa1 and Taq1 is associated with the increased risk of type 2 diabetes. We think that we need a larger number of volunteers to reach a more accurate conclusion.

Resumo Várias razões podem estar subjacentes ao aumento dramático da diabetes mellitus tipo 2. Um desses motivos é a base genética e variações. Os polimorfismos do receptor da vitamina D estão associados a diferentes doenças, como artrite reumatoide e diabetes. O objetivo deste estudo é investigar a possível associação de duas mutações identificadas ApaI (rs7975232) e TaqI (rs731236). Oitenta e nove indivíduos saudáveis ​​e 56 pacientes com diabetes tipo 2 (T2D) foram investigados usando a técnica RFLP para genotipagem e haplotipagem também. A distribuição dos genótipos Apal não foi estatisticamente significativa entre o controle (P = 0,65), bem como para os pacientes diabéticos (P = 0,58). Para as frequências do alelo Taql, o alelo T foi de 0,61, onde o alelo G foi de 0,39. A distribuição de frequência dos genótipos Taql não foi estatisticamente significativa entre o controle (P = 0,26), bem como os pacientes diabéticos (P = 0,17). O risco relativo do alelo T do gene Apa1 é 1,28 e a razão de chances do mesmo alelo é 1,53, enquanto ambas as estimativas foram < 1,0 do alelo G. Da mesma forma, com o gene Taq1, os valores de risco relativo e razão de chances para o alelo T são 1,09 e 1,27, respectivamente, e ambas as estimativas do alelo C foram de 0,86 para o risco relativo e 0,79 para o odds ratio. O desequilíbrio de ligação par a par entre os dois SNPs Taq1 / apa1 foi estatisticamente significativo no grupo de controle (D = 0,218, D' = 0,925 e valor P < 0,001) e dados semelhantes em grupos diabéticos (D = 0,2, D' = 0,875 e valor P < 0,001). Esses dados sugerem que o alelo T de ambos os genes Apa1 e Taq1 está associado ao aumento do risco de diabetes tipo 2. Achamos que precisamos de um número maior de voluntários para chegar a uma conclusão mais precisa.

Interposición hepatodiafragmática del colon / Hepatodiaphragmatic Interposition of the Colon

Hombre de 72 años con antecedentes de diabetes mellitus tipo 2 y sustitución protésica de cadera derecha hace dos años, que ingresó por dolor localizado en región posterolateral del miembro inferior derecho y dificultad para deambular. El examen físico mostró mucosas hipocoloreadas, abdomen depresible e indoloro con borramiento de la submatidez hepática normal e impotencia funcional con calor y dolor en la articulación coxofemoral. La radiografía del tórax (figura A) reveló un hemidiafragma derecho elevado y el colon transverso estaba interpuesto entre el hígado y el diafragma. Esta anormalidad anatómica es conocida como el signo de Chilaiditi y puede conducir a un diagnóstico falso positivo de neumoperitoneo (figura B de archivo). El signo de Chilaiditi se debe casi siempre a la interposición del colon transverso, aunque puede ser intestino delgado. Cuando se asocia al dolor abdominal, la entidad recibe el nombre de síndrome de Chilaiditi(AU)

Riesgo de desarrollar diabetes mellitus tipo 2 según escala Finnish Diabetes Risk Score en atención primaria / Risk of Developing Type 2 Diabetes Mellitus According to the Finnish Diabetes Risk Score in Primary care

Introducción: La diabetes mellitus tipo 2, representa 90-95 por ciento de todas las diabetes, es una enfermedad crónica potencialmente prevenible, la escala Finnish Diabetes Risk Score es uno de los instrumentos más utilizados a nivel mundial para evaluar el riesgo de presentar diabetes en 10 años con enfoque fácil y económico. Objetivo: Determinar el riesgo de desarrollar diabetes en los próximos 10 años según escala Finnish Diabetes Risk Score en pacientes en una Unidad Médica Familiar de México. Métodos: Estudio transversal analítico, se aplicó la escala Finnish Diabetes Risk Score a 383 pacientes y se analizaron las variables implicadas en dicha escala, las variables edad e índice de masa corporal se describieron con medidas de tendencia central, las variables sexo, escolaridad, así como aquellas dicotómicas y de intervalo, mediante razones y proporciones. Se midió asociación mediante Odds Ratio para dicotómicas y coeficiente de Spearman para numéricas. Resultados: La mediana de edad fue de 47 años, predominó el sexo femenino, el 71,5 por ciento reportó sedentarismo, el 51,9 por ciento refirió un familiar de primer grado con diabetes, se determinó probabilidad del 67 por ciento de tener peso normal al realizar actividad física diaria; se determinó una probabilidad del 65 por ciento de presentar prediabetes si se tiene sobrepeso u obesidad, se determinó asociación lineal entre índice de masa corporal y edad, el riesgo predominante para desarrollar diabetes mellitus tipo 2 en 10 años fue alto. Conclusiones: El riesgo de desarrollar diabetes en 10 años en la población estudiada fue elevado y se relacionó con falta de actividad física, antecedentes familiares y sobrepeso(AU)

Introduction: Type 2 diabetes mellitus, accounts for 90-95 percent of all diabetes. It is a potentially preventable chronic disease. The Finnish Diabetes Risk Score is one of the most widely used instruments worldwide to assess the risk of developing diabetes in 10 years with an easy and inexpensive approach. Objective: To determine the risk of developing diabetes in the next 10 years according to the Finnish Diabetes Risk Score in patients in a Family Medical Unit in Mexico. Methods: Analytical cross-sectional study. The Finnish Diabetes Risk Score was applied to 383 patients and the variables involved in this scale were analyzed. The variables age and body mass index were described with measures of central tendency, while the variables gender, schooling, as well as dichotomous and interval variables, were described by ratios and proportions. Association was measured by Odds Ratio for dichotomous variables and Spearman's coefficient for numerical variables. Results: The average age was 47 years and female gender predominated. Sedentary lifestyle was reported by 71.5 percent and 51.9 percent reported a first-degree relative with diabetes. A 67percent probability of having a normal weight was determined when performing daily physical activity. In addition, a 65percent probability of having prediabetes was established if overweight or obese, and a linear association was found between body mass index and age. The predominant risk for developing type 2 diabetes mellitus in 10 years was high. Conclusions: The risk of developing diabetes in 10 years in the studied population was high and was related to lack of physical activity, family history and overweight(AU)

Cuidado farmacêutico em diabetes mellitus tipo 2: um desafio a ser enfrentado / Pharmaceutical care in type 2 diabetes: a challenge to be faced

Dentre as doenças crônicas não transmissíveis mais prevalentes no panorama atual, o diabetes mellitus desponta não somente como doença de maneira isolada, mas também como resultado das suas inúmeras complicações. É caracterizado por uma síndrome de etiologia múltipla, com hiperglicemia persistente em decorrência dos defeitos na produção de insulina ou na sua ação sobre as células. Objetivo: Analisar o impacto do Cuidado Farmacêutico no controle glicêmico de usuários de Unidades de Saúde com diagnóstico de diabetes mellitus tipo 2 (DM2) em um município de pequeno porte do Paraná. Método: Estudo quantitativo realizado entre setembro de 2021 à março de 2022, que analisou desfechos clínicos como glicemia de jejum, hemoglobina glicada (HbA1c) e microalbuminúria em pacientes com diagnóstico de DM2. Resultados: Dos 17 participantes, 11 eram do sexo feminino (64,7%), com média de idade de 60,4 anos (dp ± 10,7), variando entre 41 e 79 anos. Ocorreu uma discreta redução na média dos resultados de HbA1c depois do Cuidado Farmacêutico, passando de 9,9% no início do estudo para 9,2% ao final dele. Entretanto, houve uma melhora substancial nos níveis de HbA1c em 58,8% dos pacientes, observando-se 53% de redução para um dos indivíduos acompanhados. Conclusões: Bons resultados foram evidenciados durante o processo de Cuidado Farmacêutico em pacientes com DM2, onde verificou-se a diminuição clinicamente importante dos índices de HbA1c, o que influencia na redução das complicações decorrentes da doença

Among the most prevalent non-communicable chronic diseases in the current scenario, diabetes emerges not only as a disease in isolation but also as result of the countless complications. It is characterized by a syndrome of multiple etiologies, with persistent hyperglycemia due to defects in insulin production or in its action on cells. Objetctive: Analyze the impact of Pharmaceutical Care on the glycemic control of users of basic health units diagnosed with type 2 diabetes (DM2) in a small city in Parana. Method: Quantitative study carried out between September 2021 and march 2022, that analyzed clinical outcomes such as fasting blood glucose, glycated hemoglobin (HbA1c) and microalbuminuria in patients diagnosed with DM2. Results: Of the 17 participants, 11 were female (64,7%), with a mean age od 60.4 years (sd ± 10.7), ranging between 41 and 79 years. There was a slight reduction in mean HbA1c results after Pharmaceutical Care, from 9.9% to 9.2% at the end of the study. However, there was a substantial improvement in these values in 58.8% of the patients, reaching a 53% reduction for one of the followed individuals. Conclusions: Good results were evidenced during the Pharmaceutical Care process in user with DM2, with a significant decrease in glycated hemoglobin levels, which influences the reduction of complications resulting from the disease

The distribution of blood pressure and associated factors of the elderly with type 2 diabetes in Jiangsu Province / 中华预防医学杂志

Objective: To investigate the distribution of blood pressure and analyze the associated factors of blood pressure of the elderly with type 2 diabetes in Jiangsu Province. Methods: The elderly over 60 years old participants with type 2 diabetes in the communities of Huai'an City and Changshu City, Jiangsu Province were selected in this study. They were divided into two groups: taking antihypertensive drugs and not taking antihypertensive drugs. The demographic characteristics, such as age and sex, and relevant factors were collected by questionnaire. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured by physical examination. The percentile of SBP and DBP in each age group of men and women were described. The kernel density estimation curve was used to show the blood pressure distribution. The trend of blood pressure with age was fitted by locally weighted regression. The logistic regression model was used to analyze relevant factors of blood pressure. Results: A total of 12 949 participants were included in this study, including 7 775 patients in the antihypertensive drug group and 5 174 patients in the group without antihypertensive drugs. The SBP of participants was concentrated at 140-160 mmHg, and their DBP was concentrated at 75-85 mmHg. There were significant differences in the distribution of blood pressure among the subgroups of body mass index (BMI) and rural areas whether taking antihypertensive drugs and not. For participants aged under 80 years old, the SBP showed an increasing trend with age and the DBP showed a decreasing trend with age. Age, BMI ≥24 kg/m2, fasting blood glucose ≥7.0 mmol/L, living in rural areas and no smoking were influencing factors of the elevated SBP; BMI ≥24 kg/m2, male, living in rural areas, no smoking, drinking alcohol and not receiving drug hypoglycemic treatment were influencing factors of the elevated DBP. Conclusion: The SBP of older diabetic adults in Jiangsu Province is at a high level, and the distribution of blood pressure is significantly different between men and women in taking antihypertensive drugs group. The SBP presents a rising trend and the DBP is decreasing at the age of 60-80 years. The blood pressure level of this population are mainly affected by age, BMI, urban and rural areas, smoking.

Risk for type 2 diabetes mellitus death attributed to insufficient whole grain intake in seven regions of China, 2005-2018 / 中华流行病学杂志

Objective: To estimate the risk for type 2 diabetes mellitus (T2DM) death attributed to insufficient whole grain intake in seven regions of China from 2005 to 2018. Methods: Based on China National Nutrition and Health Surveys and China Adult Chronic Disease and Nutrition Surveillance, ordinary Kriging method and locally weighted regression were used to estimate the level of whole grain intake of Chinese residents from 2005 to 2018. Based on the results of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 and Chronic Diseases Risk Factors Surveillance in China, we calculated the population attributable fraction (PAF), attributable death number and attributable mortality rate of T2DM due to insufficient whole grain intake in people aged ≥20 years in different regions of China, and we used the 2010 Chinese census data to compare the changes in T2DM deaths attributed to insufficient intake of whole grains in seven regions of China. Results: The whole grain intake levels of Chinese people over 20 years old in 2002, 2010 and 2015 were 19.0 g/d, 14.3 g/d and 19.8 g/d, respectively. The estimated overall whole grain intake level was 20.1 g/d in Chinese residents in 2018, and the intake level was 19.4 g/d in men and 20.8 g/d in women. Among the seven regions, the intake level was highest in northern China (47.4 g/d) and lowest in southwestern China (6.0 g/d). In 2018, the PAF was lowest in northern China (12.8%) and highest in southwestern China (19.3%). From 2005 to 2018, the PAF varied in the seven regions, and the PAF in northeastern China fluctuated around 18.5%. Other regions showed downward trends, especially in northern China and northwestern China, decreased by 26.4% and 21.2%, respectively. Over the past 14 years, the number of attributable deaths in the seven regions showed upward trends, with the highest annual average growth rate of 6.7% in southern China and the lowest annual average growth rate of 2.4% in northern China. In 2018, the standardized T2DM mortality rate attributed to insufficient whole grain intake in China was 3.13/100 000, and the attributable mortality was 3.21/100 000 in men and 3.05/100 000 in women. The standardized attributable mortality rate was highest in southwestern China (3.97/100 000) and lowest in northern China (1.78/100 000). From 2005 to 2018, the standardized attributable mortality rate increased by 11.5% in men and decreased by 8.1% in women. The standardized attributable mortality rate in southwestern, southern and central China increased by 23.7%, 21.3% and 4.2%, respectively. The standardized attributable mortality rate in northern, northwestern, eastern and northeastern China decreased by 20.9%, 11.0%, 4.5% and 3.9%, respectively. Conclusion: The whole grain intake level of Chinese residents was low, and the whole grain intake of residents in all seven regions should be increased, especially in the southwest, and men should have more whole grain intake than women to reduce the death risk in patients with T2DM.

Factores más influyentes que la hipertensión para el desarrollo de diabetes mellitus 2 / Factor Influencing more than Hypertension in the Development of Type 2 Diabetes Mellitus

Por medio de la presente queremos comentar acerca del artículo desarrollado por Góngora y otros (2021) acerca del Riesgo estimado de padecer diabetes mellitus tipo 2 (DM2) en pacientes hipertensos con tratamiento farmacológico.(1) Nos parece interesante la manera en la cual se ha desarrollado el artículo, sobre la relación que tiene la hipertensión arterial de debut como factor de riesgo directo para padecer DM2. Sin embargo, creemos que no se les da la debida importancia a otros factores con mayor predominio en el desarrollo de la DM2, como los que detallamos a continuación. Por ejemplo, Soares y otros (2014) demuestran que el factor de riesgo para DM2 más prevalente fue el sedentarismo, seguido por el exceso de peso, obesidad, glucosa plasmática e hipertensión arterial, todo esto ligado a malos hábitos alimenticios(2)(AU)

Algunas características del tratamiento con insulina en el paciente con diabetes mellitus tipo 2 / Some Characteristics of Insulin Treatment in Patients with Type 2 Diabetes Mellitus

Introducción: La insulina es un importante fármaco que puede ser empleado en el tratamiento del paciente diabetes mellitus tipo 2. Objetivo: Describir algunas de las características del tratamiento con insulina en el paciente con diabetes mellitus tipo 2. Métodos: La información necesaria para redactar el presente artículo se obtuvo en el trimestre octubre-diciembre de 2020. Se utilizó como motores de búsqueda de información científica a Google Académico, Pubmed y Scielo. Se evaluaron diferentes trabajos de revisión, de investigación y páginas web, que en general tenían menos de 10 años de publicados, en idioma español, portugués o inglés. Fueron utilizadas como palabras clave: tratamiento; insulina; análogos de insulina; diabetes mellitus. Fueron excluidos los artículos que no reunían las condiciones señaladas. Esto permitió el estudio de 80 artículos, de los cuales 43 fueron referenciados. Conclusiones: La insulina es una hormona polipeptídica sintetizada por las células β de los islotes de Langerhans del páncreas. Su efecto es ejercido fundamentalmente a nivel del hígado, tejido adiposo y músculo, y es una opción terapéutica en cualquier fase evolutiva de la diabetes mellitus tipo 2, cuando los agentes orales no logran las metas o si se presentan ciertas complicaciones. Se dispone de una amplia gama de tipos de insulina con distintos perfiles de acción y concentración, lo que permite clasificarlas de diferentes maneras. Se han establecido diferentes criterios sobre cuándo se debe comenzar y cómo orientar el tratamiento con insulina en la persona con diabetes mellitus tipo 2, lo que hacen posible un mejor control glucémico(AU)

Introduction: Insulin is an important drug that can be used for providing treatment to the patient with type 2 diabetes mellitus. Objective: To describe some of the characteristics of insulin treatment in patients with type 2 diabetes mellitus. Methods: The necessary information for writing this article was obtained in the trimester October-December 2020. As search engines for scientific information, Google Scholar, Pubmed and SciELO were used. Different review papers, research papers and web pages were assessed, generally less than ten years old and published in Spanish, Portuguese or English. The following keywords were used: tratamiento [treatment], insulina [insulin]; análogos de insulina [insulin analogues], diabetes mellitus. The articles not meet the above conditions were excluded. This allowed the study of eighty articles, of which 43 were referenced. Conclusions: Insulin is a polypeptide hormone synthesized by the β cells of the islets of Langerhans of the pancreas. Its effect is produced primarily at the liver, adipose tissue and muscle levels. It is a therapeutic option in any evolutionary phase of type 2 diabetes mellitus, when oral agents fail to achieve goals or if certain complications occur. A wide range of insulin types with different action and concentration profiles are available, allowing them to be classified in different ways. Different criteria have been established about when to start and how to guide insulin treatment in the person with type 2 diabetes mellitus, making better glycemic control possible(AU)

Asociación entre el índice de amputación por pie diabético y los indicadores de atención y manejo de diabetes mellitus tipo 2 en los Centros de Salud del Servicio Metropolitano Oriente, entre 2014 y 2018 / Association between the diabetic foot amputation index and metabolic compensation in diabetes mellitus

BACKGROUND: Diabetic foot amputation is a public health challenge due to the increasing prevalence of type 2 diabetes mellitus (T2D). Although there are many health indicators aimed at the management and control of T2D and its complications, amputations persist. Aim: To evaluate the association between diabetic foot amputation index and indicators of care and management of T2D in primary care centers of the eastern section of Santiago, Chile. MATERIAL AND MATHODS: We conducted a mixed ecological study and included information from the Monthly Statistical report of different public health centers from 2014 to 2018. We also analyzed the hospital discharge records from an individual tertiary public health center. The annual index for diabetic foot amputation per 100,000 diabetic patients was used as a response variable. The diabetic compensation percentage was calculated as the proportion of adults with a glycosylated hemoglobin below 7% or the proportion of older people with a value below 8%. The diabetic decompensation percentage was calculated as the proportion of people with a glycosylated hemoglobin over 9%. RESULTS: A high variability in demographic and management indicators was observed between communes and centers in the study period. Bivariate analysis showed a significant correlation between the amputation index, decompensation, and insulin use. In a regression analysis, the amputation index was significantly associated with the diabetic compensation percentage (β = -3.5; p < 0.05) and a high decompensation percentage (β = 12.3; p < 0.005). Conclusions: The diabetic foot amputation index was associated with diabetic compensation and decompensation indicators.

Relación entre la diabetes mellitus y el cáncer / Relationship between Diabetes Mellitus and Cancer

Introducción: La diabetes mellitus y el cáncer son dos problemas de salud que afectan a la población mundial. Considerar previamente el riesgo de desarrollo de cáncer en pacientes con diabetes mellitus puede contribuir de manera significativa a su prevención en este grupo de riesgo. Objetivo: Describir la relación existente entre la diabetes mellitus y el cáncer. Métodos: Se realizó una revisión bibliográfica, entre septiembre de 2019 y marzo de 2020. Se consultaron artículos científicos en Pubmed; la estrategia de búsqueda fue: diabetes mellitus [Mesh] OR diabetes mellitus[TIAB] OR diabetes mellitus, type 2[Mesh] OR type 2 diabetes mellitus[TIAB] OR obesity[Mesh] OR obesity[TIAB] OR hyperglycemia[Mesh] OR hyperglycemia[TIAB]) AND (cancer[Mesh] OR cancer[TIAB] OR neoplasia[Mesh] OR neoplasia[TIAB] OR neoplasias[Mesh] OR neoplasias[TIAB] OR neoplasm[Mesh] OR neoplasm[TIAB] OR tumors[Mesh] OR tumors[TIAB] OR tumor[Mesh] OR tumor[TIAB] OR cancers[Mesh] OR cancers[TIAB]). Se consultaron además artículos de SCOPUS, Scielo, LILACS, Biblioteca Virtual de Salud de Cuba y Google Scholar. Se seleccionaron artículos publicados a partir de 2005, con 63 por ciento de los últimos cinco años (2016‒2020). Se trabajó con 51 publicaciones. Conclusiones: Existe consenso sobre la relación entre la diabetes y el cáncer. La diabetes mellitus es un factor de riesgo para el desarrollo de cáncer, fundamentalmente en las localizaciones de páncreas, riñón, colon y recto y cuerpo uterino, ovarios y mama en la mujer; y factor protector para el cáncer de próstata en hombres. Ambas enfermedades comparten factores de riesgo no modificables (edad y sexo), modificables (dieta, actividad física, alcoholismo, entre otros) y condiciones biológicas (hiperglucemia e hiperinsulinemia)(AU)

Introduction: Diabetes mellitus and cancer are two health problems affecting the world population. Prior consideration of the risk for cancer development in patients with diabetes mellitus can contribute significantly to its prevention in this risk group. Objective: To describe the relationship between diabetes mellitus and cancer. Methods: A literature review was carried out between September 2019 and March 2020. Scientific articles were consulted in Pubmed; the search strategy was defined as it follows: diabetes mellitus[Mesh] OR diabetes mellitus[TIAB] OR diabetes mellitus, type 2[Mesh] OR type 2 diabetes mellitus[TIAB] OR obesity[Mesh] OR obesity[TIAB] OR hyperglycemia[Mesh] OR hyperglycemia[TIAB]) AND (cancer[Mesh] OR cancer[TIAB] OR neoplasia[Mesh] OR neoplasia[TIAB] OR neoplasias[Mesh] OR neoplasias[TIAB] OR neoplasm[Mesh] OR neoplasm[TIAB] OR tumors[Mesh] OR tumors[TIAB] OR tumor[Mesh] OR tumor[TIAB] OR cancers[Mesh] OR cancers[TIAB]). Articles from SCOPUS, Scielo, LILACS, the Virtual Health Library of Cuba, and Google Scholar were also reviewed. Articles published from 2005 onwards were selected, with 63 percent from the last five years (2016-2020). Fifty-one publications were analyzed. Conclusions: There is consensus regarding the relationship between diabetes and cancer. Diabetes mellitus is a risk factor for the development of cancer, fundamentally in the locations of pancreas, kidney, colon and rectum, as well as the uterine body, ovaries and breast in women; while being a protective factor for prostate cancer in men. Both diseases share nonmodifiable risk factors (age and sex), modifiable risk factors (diet, physical activity, alcoholism, among others) and biological conditions (hyperglycemia and hyperinsulinemia)(AU)

Alfabetización en e-Salud en pacientes con diabetes mellitus tipo 2 al sur del Perú / E-Health Literacy In Patients with Diabetes Mellitus Type 2 in Southern Peru

La diabetes mellitus tipo 2 es un problema de salud pública a nivel mundial debido a la alta morbimortalidad asociada a sus complicaciones cardiovasculares, renales y neurológicas. Los estudios muestran que la prevalencia de diabetes en el Perú ha aumentado y se registra una incidencia de dos casos por cada cien personas al año. (1) El uso de tecnologías de información y comunicación (TIC) como aplicaciones móviles, web, redes sociales, y contenidos multimedia para el manejo de la diabetes es cada vez más frecuente aunque la efectividad de estas es aún controversial. (2) En Perú, se encontró un uso poco frecuente (menos del 20 por ciento) de las TIC en pacientes diabéticos. (3, 4) Este uso poco frecuente probablemente se deba a al limitado acceso a estas tecnologías por los costos que implica aunque cada vez los precios son más bajos, otra posible explicación es la insuficiente o nula alfabetización digital. Ningún estudio ha evaluado el nivel de alfabetización en e-Salud o alfabetización digital en salud de pacientes dentro del contexto peruano. El objetivo fue evaluar de forma exploratoria la alfabetización en e-Salud en un grupo de pacientes diabéticos(AU)

Type 2 diabetes mellitus is a public health problem worldwide due to the high morbidity and mortality associated with its cardiovascular, renal and neurological complications. Studies show that the prevalence of diabetes in Peru has increased and there is an incidence of two cases per hundred people per year. The use of information and communication technologies (ICT) such as mobile applications, web, social networks, and multimedia content for diabetes management is increasingly frequent, although their effectiveness is still controversial. In Peru, infrequent use (less than 20 percent) of ICT was found in diabetic patients. This infrequent use is probably due to the limited access to these technologies due to the costs involved, although prices are increasingly lower, another possible explanation is insufficient or no digital literacy. No study has evaluated the level of e-Health literacy or digital health literacy of patients within the Peruvian context. The objective was to evaluate in exploratory way e-Health literacy in a group of diabetic patients(AU)

Hábito Alimentar de Idosos Diabéticos e não Diabéticos: Vigitel, Brasil, 2016 / Eating Behavior of Older Adults with and Without Diabetes: The Vigitel Survey, Brazil, 2016

Resumo Fundamentos A alimentação saudável é um fator de proteção contra o diabetes tipo 2 e desempenha importante papel no tratamento do diabetes e das comorbidades associadas. Objetivo Caracterizar o hábito alimentar de idosos diabéticos e não diabéticos com 65 anos ou mais, residentes nas capitais brasileiras e no Distrito Federal. Métodos Estudo transversal com dados da pesquisa Vigilância de Fatores de Risco e Proteção para as Doenças Crônicas por Inquérito Telefônico (Vigitel, 2016). Foram estimadas as prevalências de diabetes melito segundo variáveis sociodemográficas, inatividade física, autoavaliação da saúde e índice de massa corporal (IMC). O hábito alimentar foi avaliado pela frequência (semanal e diária) de consumo de alimentos saudáveis e não saudáveis, e pela substituição da comida por lanches. As diferenças foram verificadas por meio do teste Qui-quadrado de Pearson (Rao-Scott) com nível de significância de 5%. Resultados Foram entrevistados 13.649 idosos, e a prevalência de diabetes autorreferido foi de 27,2% (IC95%:25,5; 29,0). Nos pacientes diabéticos, observou-se maior consumo de hortaliças cruas (32,1% vs. 26,5%/3-4 dias/semana) e menor de frango (3,8% vs. 6,4%/quase nunca/nunca), suco (24,0% vs. 29,6%) e doces (6,8% vs. 16,2%) ≥5 dias/semana. Os percentuais de idosos com consumo de leite desnatado (51,5% vs. 44,6%) e refrigerante dietético (60,0% vs. 17,3%) ≥5 dias/semana, hortaliças cruas (9,1% vs. 2,5%/no jantar) e doces (37,7% vs. 20,5%/2 vezes/dia) 3-4 dias/semana foram maiores nos diabéticos, comparados aos não diabéticos. Conclusão As diferenças observadas sinalizam a necessidade de promover intervenções para alimentação saudável entre todos os idosos, bem como orientações específicas para os diabéticos.

Abstract Background A healthy diet is a protection factor against type 2 diabetes and plays an important role in the treatment of the disease, as well as associated comorbidities. Objective Characterize the eating habits of older adults (≥ 65 years) with and without diabetes residing in capital cities and the Federal District of Brazil. Methods A cross-sectional study was conducted using data from the Surveillance of Risk and Protection Factors for Chronic Diseases Through a Telephone Survey (Vigitel, 2016). The prevalence of diabetes mellitus was estimated according to sociodemographic variables, physical inactivity level, self-rated health status and body mass index. Dietary habits were assessed based on the frequency (weekly and daily) of consumption of healthy and unhealthy foods and the replacement of food by snacks. Differences were determined using Pearson's chi-square test (Rao-Scott), with the significance level set at 5%. Results A total of 13,649 older adults were interviewed. The prevalence of self-reported diabetes was 27.2% (95% CI: 25.5; 29.0). Compared to non-diabetics, diabetic individuals had a higher consumption of raw vegetables (32.1% vs. 26.5%/3-4 days/week) and lower consumption of chicken (3.8% vs. 6.4%/hardly ever/never), fruit juice (24.0% vs. 29.6%) and sweets (6.8% vs. 16.2%) ≥ 5 days/week. Compared to non-diabetics, diabetic individuals consumed more skim milk (51.5% vs. 44.6%) and diet soda (60.0% vs. 17.3%) ≥ 5 days/week, raw vegetables (9.1% vs. 2.5%/at dinner) and sweets (37.7% vs. 20.5%/twice/day) 3-4 days/week. Conclusion The observed differences emphasize the need for healthy eating interventions for all older adults, as well as specific counseling for those with diabetes.

Incidence and risk factors of ischemic stroke in patients with type 2 diabetes among urban workers in Beijing, China / 北京大学学报(医学版)

OBJECTIVE@#To explore the incidence of ischemic stroke after the onset of type 2 diabetes, and further analyze the risk factors, so as to provide a basis for further research.@*METHODS@#The data were obtained from the database of the Beijing Urban Employee Basic Medical Insurance Database. The study used a prospective design to describe the incidence of ischemic stroke in patients with type 2 diabetes. In our study, these patients were followed up for seven years. Multivariate Logistic regression models were used to analyze the risk factors of ischemic stroke in patients with type 2 diabetes.@*RESULTS@#A total of 185 813 newly diagnosed type 2 diabetes patients were enrolled, with an average age of (58.5±13.2) years, and 49.0% of them were males. A total of 10 393 patients with newly diagnosed ischemic stroke occurred in 7 years, with a cumulative incidence of 5.6% and an incidence density of 8.1/1 000 person-years. Ischemic stroke occurred in all age groups in patients with type 2 diabetes. The cumulative incidence was 1.5% (95%CI: 1.3%-1.6%) in group ≤44 years old, 3.6% (95%CI: 3.4%-3.7%) in group 45-54 years old, 5.4% (95%CI: 5.2%-5.5%) in group 55-64 years old, and 9.2% (95%CI: 9.0%-9.4%) in group ≥65 years old, and the cumulative incidence increased with age (P < 0.05). Cumulative incidence rate of the males (6.8%, 95%CI: 6.7%-7.0%) was higher than the females (4.4%, 95%CI: 4.3%-4.6%). Among the patients < 80 years old, the cumulative incidence rate of the males was higher than that of the females in all the age groups. In the patients ≥80 years of age, the cumulative incidence was higher in the females (9.2%) than in the males (7.9%). Further analysis revealed that complications, such as coronary heart disease (OR=3.18, 95%CI: 2.72-3.72), heart failure (OR=1.53, 95%CI: 1.32-1.79) and kidney failure (OR=1.45, 95%CI: 1.20-1.75) were associated with ischemic stroke in the patients with type 2 diabetes.@*CONCLUSION@#The incidence level of ischemic stroke in patients with type 2 diabetes is high. It is necessary to strengthen the management of risk factors in elderly patients, screen the complications of type 2 diabetes as early as possible, and take active preventive and control measures.

Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China / 中华医学杂志(英文版)

BACKGROUND@#Gestational diabetes mellitus (GDM) brings health issues for both mothers and offspring, and GDM prevention is as important as GDM management. It was shown that a history of GDM was significantly associated with a higher maternal risk for GDM recurrence. The incidence of GDM recurrence was unclear because of the incidence of second-child was low before 2016 in China. We aim to investigate the prevalence of GDM recurrence and its associated high-risk factors which may be useful for the prediction of GDM recurrence in China.@*METHODS@#A retrospective study was conducted which enrolled participants who underwent regular prenatal examination and delivered twice in the same hospital of 18 research centers. All participants were enrolled from January 2018 to October 2018, where they delivered the second baby during this period. A total of 6204 women were enrolled in this study, and 1002 women with a history of GDM were analyzed further. All participants enrolled in the study had an oral glucose tolerance test (OGTT) result at 24 to 28 weeks and were diagnosed as GDM in the first pregnancy according to the OGTT value (when any one of the following values is met or exceeded to the 75-g OGTT: 0 h [fasting], ≥5.10 mmol/L; 1 h, ≥10.00 mmol/L; and 2 h, ≥8.50 mmol/L). The prevalence of GDM recurrence and development of type 2 diabetes mellitus were calculated, and its related risk factors were analyzed.@*RESULTS@#In 6204 participants, there are 1002 women (1002/6204,16.15%) with a history of GDM and 5202 women (5202/6204, 83.85%) without a history of GDM. There are significant differences in age (32.43 ± 4.03 years vs. 33.00 ± 3.34 years vs. 32.19 ± 3.37 years, P  < 0.001), pregnancy interval (4.06 ± 1.44 years vs. 3.52 ± 1.43 years vs. 3.38 ± 1.35 years, P  = 0.004), prepregnancy body mass index (BMI) (27.40 ± 4.62 kg/m2vs. 23.50 ± 3.52 kg/m2vs. 22.55 ± 3.47 kg/m2, P < 0.001), history of delivered macrosomia (22.7% vs. 11.0% vs. 6.2%, P < 0.001) among the development of diabetes mellitus (DM), recurrence of GDM, and normal women. Moreover, it seems so important in the degree of abnormal glucose metabolism in the first pregnancy to the recurrence of GDM and the development of DM. There are significant differences in OGTT levels of the first pregnancy such as area under the curve of OGTT value (18.31 ± 1.90 mmol/L vs. 16.27 ± 1.93 mmol/L vs. 15.55 ± 1.92 mmol/L, P < 0.001), OGTT fasting value (5.43 ± 0.48 mmol/L vs. 5.16 ± 0.49 mmol/L vs. 5.02 ± 0.47 mmol/L, P < 0.001), OGTT 1-hour value (10.93 ± 1.34 mmol/L vs. 9.69 ± 1.53 mmol/L vs. 9.15 ± 1.58 mmol/L, P < 0.001), OGTT 2-hour value (9.30 ± 1.66 mmol/L vs. 8.01 ± 1.32 mmol/L vs. 7.79 ± 1.38 mmol/L, P < 0.001), incidence of impaired fasting glucose (IFG) (fasting plasma glucose ≥5.6 mmol/L) (31.3% vs. 14.6% vs. 8.8%, P < 0.001), and incidence of two or more abnormal OGTT values (68.8% vs. 39.7% vs. 23.9%, P < 0.001) among the three groups. Using multivariate analysis, the factors, such as age (1.07 [1.02-1.12], P = 0.006), prepregnancy BMI (1.07 [1.02, 1.12], P  = 0.003), and area under the curve of OGTT in the first pregnancy (1.14 [1.02, 1.26], P  = 0.02), have an effect on maternal GDM recurrence; the factors, such as age (1.28 [1.01-1.61], P  = 0.04), pre-pregnancy BMI (1.26 [1.04, 1.53], P = 0.02), and area under the curve of OGTT in the first pregnancy (1.65 [1.04, 2.62], P = 0.03), have an effect on maternal DM developed further.@*CONCLUSIONS@#The history of GDM was significantly associated with a higher maternal risk for GDM recurrence during follow-up after the first pregnancy. The associated risk factors for GDM recurrence or development of DM include age, high pre-pregnancy BMI, history of delivered macrosomia, the OGTT level in the first pregnancy, such as the high area under the curve of OGTT, IFG, and two or more abnormal OGTT values. To prevent GDM recurrence, women with a history of GDM should do the preconception counseling before preparing next pregnancy.

Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus

ABSTRACT Objective: To evaluate the prevalence of osteosarcopenia and the association of osteosarcopenia with trabecular bone score (TBS) in a group of patients with type 2 diabetes mellitus(T2DMG) compared with a paired control group (CG). Materials and methods: Cross-sectional study with men and women ≥ 50 years recruited by convenience. Patients in both groups answered questionnaires and underwent evaluation of bone mineral density (BMD), handgrip strength (HGS), and TBS. The T2DMG also underwent a gait speed (GS) test. Sarcopenia was defined as low lean mass plus low HGS or GS according to the Foundation for the National Institute of Health Sarcopenia Project, and osteosarcopenia was deemed present when sarcopenia was associated with osteopenia, osteoporosis, or low-energy trauma fractures. Results: The T2DMG (n = 177) and CG (n = 146) had, respectively, mean ages of 65.1 ± 8.2 years and 68.8 ± 11.0 years and 114 (64.4%) and 80 (54.7%) women. T2DMG versus the CG had higher rates of osteosarcopenia (11.9% versus 2.14%, respectively, p = 0.010), sarcopenia (12.9% versus 5.4%, respectively, p < 0.030), and fractures (29.9% versus 18.5%, respectively, p = 0.019), and lower HGS values (24.4 ± 10.3 kg versus 30.9 ± 9.15 kg, respectively, p < 0.001), but comparable BMD values. Mean TBS values were 1.272 ± 0.11 and 1.320 ± 0.12, respectively (p = 0.001). On multivariate analysis, age, greater waist circumference, fractures, and osteoporosis increased the risk of degraded TBS. Osteosarcopenia was associated with diabetes complications (p = 0.03), calcium and vitamin D supplementation (p = 0.01), and all components of osteosarcopenia diagnosis (p < 0.05). Conclusion: Compared with the CG, the T2DMG had a higher prevalence of osteosarcopenia, sarcopenia, and fractures and lower bone quality assessed by TBS.

Riesgo de padecer diabetes mellitus tipo 2 en una población adulta del Caribe colombiano / Risk of Suffering from Type 2 Diabetes Mellitus in an Adult Population of the Colombian Caribbean

Introducción: La diabetes mellitus es una enfermedad crónica con alta prevalencia, que afecta la calidad de vida de la población que la padece, por cuanto identificar el riesgo de desarrollarla permite implementar estrategias para retrasar su aparición y prevenir complicaciones. Objetivo: Identificar el nivel de riesgo de desarrollar diabetes mellitus tipo 2 en una población del Caribe colombiano. Métodos: Estudio cuantitativo, de corte transversal. Participaron 248 individuos del área urbana de un corregimiento de Santa Marta, Colombia, en el primer semestre de 2018, mediante un muestreo estratificado por sectores. Se utilizó el test Finnish Diabetes Risk Score para la recolección de información, así como la medición del perímetro abdominal, el peso, la talla y la tensión arterial. Para el análisis de las variables numéricas se aplicó T de Student para variables independientes y para las variables categóricas se aplicó chi cuadrado. Resultados: Del total de participantes, 36,29 por ciento presentó un riesgo ligeramente elevado y 8,87 por ciento riesgo moderado alto. El grupo poblacional con mayor riesgo fue el de 58 a 65 años (34,78 por ciento). Se encontró significancia estadística entre el riesgo de presentar diabetes en los próximos 10 años y las variables sobrepeso y obesidad, circunferencia abdominal aumentada, antecedentes personales de hiperglucemia, consumo de medicamentos antihipertensivos y antecedentes personales de diabetes mellitus tipo 2 en padres, hermanos e hijos. Conclusiones: El riesgo de desarrollar diabetes mellitus tipo 2 en la población estudiada fue ligeramente elevado en un alto porcentaje de la población(AU)

Introduction: Diabetes mellitus is a chronic disease with high prevalence, which affects the quality of life of the population that suffers from it, since identifying the risk of developing it allows the implementation of strategies to delay its onset and prevent complications. Objective: To identify the level of risk of developing type 2 diabetes mellitus in a Colombian Caribbean population. Methods: This is a quantitative, cross-sectional study. two hundred forty eight individuals from the urban area of a village in Santa Marta, Colombia, participated in the first semester of 2018, through a sampling stratified by sectors. The Finnish Diabetes Risk Score test was used to collect information, as well as to measure abdominal circumference, weight, height, and blood pressure. For the analysis of the numerical variables, Student's t-test was applied for independent variables and chi-square was applied for the categorical variables. Results: Of the total of participants, 36.29 percent had slightly high risk and 8.87 percent moderate high risk. The population group with the highest risk was 58 to 65 years (34.78 percent). Statistical significance was found between the risk of developing diabetes in the subsequent 10 years and the variables overweight and obesity, increased abdominal circumference, personal history of hyperglycemia, consumption of antihypertensive drugs, and personal history of type 2 diabetes mellitus in parents, siblings, and children. Conclusions: The risk of developing type 2 diabetes mellitus in the studied population was slightly elevated in a high percentage of the population(AU)

Validación de instrumentos para diabetes mellitus tipo 2 en adultos mayores / Instrument validation for older adults with type 2 diabetes mellitus

Una de las principales dificultades en la atención al adulto mayor diabético continúa siendo la falta de educación hacia un estilo de vida y una actitud favorable hacia la enfermedad, lo cual solo puede lograrse mediante estrategias educativas. Objetivo: Validar los instrumentos AM1 ­ MO de la investigación factores modificables y su influencia en la presencia de complicaciones en adultos mayores con Diabetes Mellitus tipo 2 en el club de adultos mayores Lupita Nolivos en la Carrera de Enfermería de la Universidad de Guayaquil, en los periodos de septiembre a diciembre 2019. Materiales y Métodos: El Instrumento AM1 ­MO se realizó un estudio descriptivo, exploratorio y transversal, este instrumento cuantitativo se aplicó al universo de 50 adultos mayores entre 55 y 65 años y más, utilizando el SOFTWARE IBM SPSS Statistics Base 22.0. Resultados: Del total de pacientes con DMT2, el sexo femenino estuvo representado con 60,0 % y el masculino aportó 40,0 %. El grupo de edad de 70-79 fue el de mayor predominio de dicha afección con 62,0 %, de ellos 18 eran mujeres y 13 hombres. En cuanto a los hábitos alimentarios resulto se obtuvo los siguientes resultados que hay un alto consumo de gaseosas y dulces 24%. Conclusiones: En este trabajo se identificó que las personas que tienen mayor riesgo de desarrollar DMT2 son aquellas que tienen una edad superior a 55 años, presentan antecedentes familiares para esta enfermedad, son del sexo femenino, presentan exceso de peso, son físicamente inactivas y padecen HTA. En conclusión, el instrumento construido constituye una aproximación para determinar los factores modificables y su influencia en la presencia de complicaciones en adultos mayores con diabetes mellitus tipo 2. Los resultados obtenidos por las diferentes vías para evaluar los instrumentos utilizados fueron adecuados. Está disponible un instrumento válido y confiable que justifica su uso y aplicación en el ámbito investigativo(AU)

One of the main difficulties in caring for the elderly with diabetes continues to be the lack of education towards a lifestyle and a favorable attitude towards the disease, which can only be achieved through educational strategies. Objective: to validate the AM1 ­ MO instrument of the research, modifiable factors and their influence on the presence of complications in older adults with Type 2 Diabetes Mellitus in the Lupita Nolivos club for older adults in the Nursing Career of the University of Guayaquil, in the periods from September to December 2019. Materials and Methods: The AM1-MO Instrument was carried out a descriptive, exploratory and cross-sectional study, this quantitative instrument was applied to the universe of 50 older adults between 55 and 65 years old and over, using the IBM SPSS SOFTWARE Statistics Base 22.0. Results: Of the total number of patients with T2DM, the female sex was represented with 60.0% and the male contributed 40.0%. The age group 70-79 was the one with the highest prevalence of this condition with 62.0%, of which 18 were women and 13 were men. Regarding eating habits, the following results were obtained that there is a high consumption of soda and sweets 24%. Conclusions: In this work it was identified that the people who have a higher risk of developing T2DM are those who are older than 55 years, have a family history for this disease, are female, are overweight, are physically inactive and suffer from HTA. In conclusion, the instrument constructed constitutes an approximation to determine the modifiable factors and their influence on the presence of complications in older adults with type 2 diabetes mellitus. The results obtained by the different ways to evaluate the instruments used were adequate. A valid and reliable instrument is available that justifies its use and application in the research field(AU)